Loading...
PhD Janja Ocvirk

PhD Janja Ocvirk
no.: 13541 source: ARIS

researcher – active in research organisation
Phone number (01) 587 92 83
E-mail jocvirkat signonko-i.si
Foreign language skills
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
Keywords
Melanoma, lymphoma
Points
612.26
A''
39.17
A'
89.84
A1/2
164.17
CI10
1,198
CImax
515
h10
17
A1
1.83
A3
9.45
Data for the last 5 years (citations for the last 10 years) on December 4, 2023; A3 for period 2017-2021 (update for tender in 2022: YES)
Data for ARIS tenders ( 14.06.2023 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 92  1,210  1,155  12.55 
Scopus 45  1,367  1,317  29.27 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Eva Erzar  Bologna doctoral studies  10/1/2020 - 9/30/2024  53393 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
Bachelor's degree      SI University of Ljubljana, Faculty of Medicine 1991 
Master's degree    Oncology  SI University of Ljubljana, Faculty of Medicine 1995 
Specialization      SI University of Ljubljana, Faculty of Medicine 1997 
Doctor's degree  Ph. D.     SI University of Ljubljana, Faculty of Medicine 2000 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Title
Full time employment (90%, RD:30%)  Institute of Oncology Ljubljana  Department of research  12/22/1992  Medical oncologyst  Full professor 
Full time employment (25%, RD:5%)  Universita del Litorale, Facolta di Scienze della Salute  Raziskovalna skupina UP FVZ (Slovene)  8/1/2022  Full professor  Full professor 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J3-6796  Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin   2014 - 2017  PhD Maja Čemažar  4,612 
2. J3-4211  Antiangiogenic gene therapy of cancer using electroporation and magnetic nanoparticles as targeted delivery systems   2011 - 2014  PhD Gregor Serša  6,347 
3. L2-4105  Development and validation of a software for numerical modeling of in vivo electroporation - in silico electroporation   2011 - 2014  PhD Damijan Miklavčič  4,712 
4. L3-6059  Prospektivna randomizirana klinična raziskava faze ll: 5-FU/LV in Irinotekan v primerjavi s kombinacijo Kapecitabin in Irinotekan v prvem zdravljenju metastatske bolezni pri bolnikih s karcinomom debelega črevesa in danke (Slovene)   2004 - 2007  PhD Janja Ocvirk  1,796 
5. J3-4203  Adjuvantno zdravljenje bolnikov z malignim melanomom stadij llB,C z interferonom alfa-2A (Slovene)   2002 - 2005  PhD Zvonimir Rudolf  4,339 
6. J3-4178  Pomen okultnih metastaz v pazdušnih bezgavkah pri zgodnjem karcinomu dojke (Slovene)   2002 - 2005  PhD Matej Bračko  2,048 
7. J3-3464  Role of tyrosinase RT-PCR in staging of patients with malignant melanoma   2002 - 2004  PhD Marko Hočevar  2,757 
8. L3-1259  Modulacija imunskega odziva pri bolnikih z malignim melanomom rezistentnim na kemoterapijo (Slovene)   1999 - 2001  PhD Borut Štabuc  2,778 
9. J3-0146  Zdravljenje malignih solidnih tumorjev z interferonom alfa (Slovene)   1998 - 2001  PhD Borut Štabuc  2,295 
ARIS research and infrastructure programmes Legend
source: ARIS
Views history
Favourite